Our Deals

• 2019.01.15Grandway advised the public issuance of convertible bond of China Nuclear Engineering&Construction Group Corporation Limited (Stock Code:601611) which received approval of CRSC on January 15, 2019.
• 2019.01.12Grandway assists the client to win a administrative litigation case with Wanning municipal government regarding the disputes of expropriation of land use right.
• 2019.01.12Grandway assists the client that being accused for insider trading to receive the positive result in such insider trading case.
• 2019.01.11Grandway assists the client to win a administrative litigation case with Wanning municipal government regarding the disputes of expropriation of land use right.
• 2019.01.11Grandway advised the public issuance of 2 billions renewable corporate bond of China Nuclear Engineering&Construction Group Corporation Limited (Stock Code:601611) on Janauray 11,
• 2018.12.29Grandway advised the private placement of Anhui Genuine New Materials Co.,Ltd. (Stock Code:603429) which received approval of CRSC on December 24, 2018.
• 2018.12.28Grandway advised Jiangxi Fushine Pharmaceutical Co., Ltd.(Stock Code:300497) on its issuance of convertible corporate bond on Shenzhen Stock Exchange which received the approval from CSRC on December
• 2018.12.28Grandway advised Jiangxi Fushine Pharmaceutical Co., Ltd.(Stock Code:300497) on its issuance of convertible corporate bond on Shenzhen Stock Exchange which received the approval from CSRC on December
• 2018.12.28With the legal service of Grandway, Wuxi Shangji Automation Co., Ltd. (Stock Code:603429) has been succesfully listed on SSE on December 28, 2018.
• 2018.12.28Grandway provides legal service to a subsidary of Poly Group for successfuly developing the largest urban redevelopment project in Chengdu province.
• 2018.12.27Grandway advised the significant asset restructuring of Zhejiang Sanwei Rubber Item Co.,Ltd. (Stock Code: 603033) which received approval of CRSC on November 27, 2018.
• 2018.12.25Grandway advised the public issuance of convertible bond of Jiangxi Fushine Pharmaceutical Co., Ltd. (Stock Code: 300497 ) which received approval of CRSC on December 25, 2018.
• 2018.12.25Grandway advised the public issuance of convertible bond of Jiangxi Fushine Pharmaceutical Co., Ltd. (Stock Code: 300497 ) which received approval of CRSC on December 25, 2018.
• 2018.12.10Recently, the first-instance judgement of GAC Hino’s product liablity case has been reversed in the trial of second instance with the professional legal assistance of Grandway.
• 2018.12.04Grandway Advised the IPO and the Listing of WPG (Shanghai) Smart Water Public Co., Ltd Which Received Approval of CRSC.
• 2018.11.30Grandway advised PCI-SUNTEK Technology Co., Ltd. (Stock Code:600728) on its issuance of convertible corporate bond on Shanghai Stock Exchange which received the approval from CSRC on October 30, 2018.
• 2018.11.22Grandway Advised Avic International Leasing Co., Ltd. Successfully Issuing 1.9 Billion Asset-Backed Security on November 22, 2018.
• 2018.11.19Grandway Advised Huayuan Property (Stock Code: 600743) Successfully Issuing US Dollar Bonds on HK Stock Exchange on November 19, 2018.
• 2018.11.14Grandway advised the significant asset restructuring of Addsino Co.,Ltd (Stock Code: 000547) which received approval of CRSC on November 14, 2018.
• 2018.11.12Grandway advised Nanjing Hanrui Cobalt Co.,Ltd. (Stock Code:300618) on its issuance of convertible corporate bond on Shenzhen Stock Exchange on November 20, 2018.